The authors concluded that glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations were usually higher and ghrelin levels were usually lower in participants undergoing Roux-en-Y gastric bypass surgery compared with various comparator conditions. Given the potential for error and bias in the review, the limited search and the unclear quality of included studies, the authors' conclusions should be treated with caution.
Study selection
Studies that evaluated the impact of Roux-en-Y gastric bypass surgery on glucagon-like peptide-1, peptide tyrosinetyrosine, ghrelin (gastrointestinal hormones) and/or leptin in participants with no previous weight loss surgeries were eligible for inclusion. Case studies and studies that did not differentiate between surgery types in their analyses were excluded.
The included studies compared Roux-en-Y gastric bypass with a variety of other gastrointestinal or anti-reflux surgeries in non-surgical lean, healthy, overweight or obese participants, or participants achieving weight loss through lifestyle modification. Within-subject study designs comparing pre-and post-surgery gastrointestinal hormone levels were also included. Most of the participants were female (where reported). Limb length ranged from 40cm to 150cm. Some studies included participants with diabetes. Outcomes were assessed using fasted blood samples, oral glucose tolerance tests, or plasma collection.
The authors did not state how many reviewers performed the study selection.
Assessment of study quality
A formal validity assessment was not conducted. For glucagon-like peptide-1, peptide tyrosine-tyrosine and ghrelin, a study was considered strong if it had a control group and/or sampled outcomes at multiple time points after meal consumption. For leptin, a study was considered strong if it had a control group.
Data extraction
The authors did not state how the data were extracted for the review.
Methods of synthesis
The studies were combined in a narrative synthesis.
Results of the review
Forty-six studies were included for review (n=1,247 participants). One articles reported on three studies, so it was unclear whether there was any overlap in these study populations. There was one double-blind randomised controlled trial (n=13 participants), 16 prospective or retrospective controlled studies (n=477 participants), 14 prospective uncontrolled studies (n=302 participants) and 15 cross-sectional controlled studies (n=455 participants).
Glucagon-like peptide-1 changes (16 studies, 14 articles): Five of the six studies comparing Roux-en-Y gastric bypass with weight-matched non-surgical participants found significant increases in glucagon-like peptide-1 in the surgery
